UnitedHealth Group reported strong Q1 results with revenue growth and increased membership across all businesses. Management maintained earnings guidance despite acknowledging future headwinds from Medicare Advantage funding cuts and sequestration. The company's diversified businesses and optimistic outlook suggest a positive short-term impact on the stock price.

[1]